BALDINI, LUCA
BALDINI, LUCA
Dipartimento di Oncologia ed Emato-Oncologia
10-year results with moppebvcad chemotherapy nad optional, limited radioterapy in advanced Hodgkin lymphoma
2005 P. Gobbi, C. Broglia, F. Valentino, A. Levis, M. Federico, T. Chisei, E. Iannitto, E. Pavone, M. Brugiatelli, L. Baldini
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND
2005 S. Fabris, D. Intini, L. Agnelli, M. Mattioli, S. Bicciato, D. Verdelli, L. Rossini, L. Baldini, F. Morabito, V. Callea, G. Lambertenghi Deliliers, A. Zanella, L. Lombardi, A. Neri
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)
2021 C. Boccomini, M. Ladetto, L. Rigacci, B. Puccini, S. Rattotti, S. Volpetti, S. Ferrero, A. Chiarenza, R. Freilone, M. Novo, P. Corradini, L. Nassi, C. Rusconi, C. Stelitano, S. Bolis, A. Marina Liberati, A. Tucci, L. Baldini, M. Balzarotti, A. Evangelista, G. Ciccone, U. Vitolo
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
2021 M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias
2015 M. Lionetti, M. Barbieri, K. Todoerti, L. Agnelli, S. Fabris, G. Tonon, S. Segalla, I. Cifola, E. Pinatel, P. Tassone, P. Musto, L. Baldini, A. Neri
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias
2008 M. Goldaniga, A. Ferrario, S. Cortelazzo, A. Guffanti, E. Pavone, A. Ambrosetti, L. Marcheselli, F. Rossi, S. Luminari, A. Rossi, L. Cro, M. Federico, G. Lambertenghi Deliliers, L. Baldini
A new antigen specificity of the M-protein in a patient with neuropathy and macroglobulinemia
1987 E. Nobile-Orazio, G. Spagnol, P. Marmiroli, L. Baldini, M. Moggio, S. Barbieri, S. Jann, N. Polli, G. Scarlato
A peculiar B-Cell subset, frequently IGVH hipermutated, is identified by a simplified immunophenotype-fish diagnostic algorithm
2005 L. Cro, L. Nobili, F. Berttoni, M. Goldaniga, A. Guffanti, S. Luminari, N. Zucal, G. Ciceri, D. Intini, A. Neri, L. Baldini, G. Lambertenghi Deliliers
A phase III study of double autotransplantation incorporating bortezomib-thalidomide-dexamethasone (VTD) or thalidomide-dexamethasone (TD) for multiple myeloma : superior clinical outcomes with VTD compared to TD
2009 M. Cavo, P. Tacchetti, F. Patriarca, M.T. Petrucci, L. Pantani, M. Galli, F. Di Raimondo, C. Crippa, S. Bringhen, M. Offidani, F. Narni, V. Montefusco, E. Zamagni, T. Spadano, N. Pescosta, L. Baldini, C. Cellini, T. Caravita, A. Ledda, A. Falcone, P. Tosi, C. Nozzoli, R. Zambello, L. Masini, P. Agostini, M. Fiacchini, M. Baccarani
A phase III study of enoxaparin versus fixed low-dos warfarin versus low-dose aspirin at thromboprophylaxis for newly diagnosed multiple myeloma patients treated with thalidomide containing regimens
2009 M. Cavo, A. Palumbo, S. Bringhen, E. Zamagni, F. Patriarca, P. Tacchetti, D. Rossi, L. Pantani, M. Cavalli, A. Levi, M. Offidani, M. Galli, G. Torelli, R. Ria, C. Nozzoli, C. Crippa, L. Baldini, V. Cellea, F. Rossini, M. Spriano, A. Capaldi, A. Baraldi, F. Gay, M. Boccadoro
A polycentric study ON CD5 negative chronic B cell leukemias
2005 M. Goldaniga, A. Ferrario, S. Cortelazzo, A. Guffanti, E. Pavone, A. Ambrosetti, L. Marcheselli, S. Luminari, A. Rossi, L. Baldini
ABDV compared with beacopp compared with cec for the intial treatment of patients with advanced hodgkin’s lymphoma : result from the HD2000 Gruppo italiano per lo studio dei linfomi Trial
2009 M. Federico, S. Luminari, E. Iannitto, G. Polimeno, L. Marcheselli, A. Montanini, A. La Sala, F. Merli, C. Stelitano, S. Pozzi, R. Scalone, N. Di Renzo, P. Musto, L. Baldini, G. Cervetti, F. Angrilli, P. Mazza, M. Brugiatelli, P.G. Gobbi.
ABDV vs Coppebvcad vs Beacopp for the initial treatment of patients with advanced hodgkin lymphoma (HL). Preliminary results of HD2000 GISL trial
2007 M. Federico, S. Luminari, M. Dell’Olio, F. Merli, M. Brugiatelli, C. Mammi, M. Musso, L. Baldini, L. Marcheselli, P.G. Gobbi
Absence of Kaposi's sarcoma--associated herpesvirus DNA sequences in multiple myeloma
1999 M. Corbellino, M. Pizzuto, G. Bestetti, L. Corsico, M. Piazza, B. Pigozzi, M. Galli, L. Baldini, A. Neri, C. Parravicini
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma
2010 A. Ferrario, F. Radaelli, M. Goldaniga, F.I. Grifoni, B. Olivero, F.G. Rossi, L. Baldini
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma : results from an Intergruppo Italiano Linfomi randomized study
2008 V. Pavone, U. Ricardi, S. Luminari, P. Gobbi, M. Federico, L. Baldini, E. Iannitto, G. Ucci, L. Marcheselli, L. Orsucci, E. Angelucci, M. Liberati, P. Gavarotti, A. Levis, Intergruppo italiano linfomi (IIL)
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin lymphoma : final results of a multicenter, randomized trial by the Intergruppo Italiano Linfomi
2005 P.G. Gobbi, A. Levis, T. Chisesi, C. Broglia, U. Vitolo, C. Stelitano, V. Pavone, L. Capanna, G. Santini, F. Merli, M. Liberati, L. Baldini, G. Lambertenghi Deliliers, E. Angelucci, R. Bordonaro, M. Federico
An information system for managing the activities of a multi-unit onco-hematological Day Hospital
2003 M. Patriarca, L. Pizzocaro, M. Gavazzi, M. Romanelli, L. Baldini, C. Boschetti, F. Onida, E. Tagliaferri, P. Monni, M. Meli, G. Lambertenghi Deliliers
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse
2014 K. Todoerti, E. Pinatel, I. Cifola, M. Lionetti, L. Mosca, E. Mangano, S. Fabris, M. Barbieri, G. Ciceri, F.G. Rossi, M.T. Petrucci, P. Musto, A. Cortelezzi, L. Baldini, G. De Bellis, C. Battaglia, A. Neri
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia
1994 G. Gaidano, E.W. Newcomb, J.Z. Gong, V. Tassi, A. Neri, A. Cortelezzi, R. Calori, L. Baldini, R. Dalla-Favera